Mobile Menu

Generic Pharmaceutical Manufacturing in Ontario

Author.Name IBISWorld Canada Last Updated: August 2025 NAICS ON32541bCA

Generic Pharmaceutical Manufacturing in Ontario industry analysis

Revenue for the Generic Pharmaceutical Manufacturing industry in Ontario is expected to decline an annualized -x.x% to $x.x billion over the five years to 2025, while revenue for the national industry will likely decline at -x.x% during the same period. The number of industry establishments has increased an annualized x.x% to xxx locations over the past five years. Industry employment has increased an annualized x.x% to x,xxx workers during the period, while industry wages have decreased an annualized -x.x% to $x.x million.

Over the five years to 2030, provincial industry revenue is expected to grow an annualized x.x% to $x.x billion, while revenue for the national industry will likely grow x.x%. The number of industry establishments is forecast to grow x.x% to xxx locations over the next five years. Industry employment is expected to increase an annualized x.x% to x,xxx workers during the outlook period, while industry wages likely increase x% to $x.x million.

Unbiased research for even more industries at your fingertips

  • 5000+Industries covered
  • 100+Local analysts
  • 250k+Hours of detailed analysis
  • 100k+Subscriber community

Purchase a membership to access this industry and so much more.

About the Generic Pharmaceutical Manufacturing in Ontario Market Research Report

What’s Included in the Generic Pharmaceutical Manufacturing in Ontario Market Research Report

Definition of the Generic Pharmaceutical Manufacturing in Ontario?

Generic pharmaceutical manufacturers produce medications that are bioequivalent to brand name drugs that regulatory agencies have already approved. These drugs contain the same active ingredients, dosage form, strength and intended use as the original brand name drugs.

What’s included in the Generic Pharmaceutical Manufacturing in Ontario?

The Generic Pharmaceutical Manufacturing in Ontario includes gaining regulatory approval for generic drugs, developing and producing generic drugs and marketing and distributing generic drugs. Related terms covered in the Generic Pharmaceutical Manufacturing in Ontario industry report includes a substance used in a finished pharmaceutical product intended to furnish pharmacological activity, drugs designed to control or kill neoplasms, or tumors, medicines made from living cells used to prevent and treat a variety of illnesses including cancer, autoimmune disorders and infectious diseases, drugs that are almost the same as a biologic drug. only slight modifications to the reference product are required for this classification, without any clinically meaningful differences, two formulations of a drug that produce similar concentrations of the active ingredient(s) in the bloodstream when administered at the exact dosage under identical conditions. this concept is crucial in the approval process of generic drugs, a comprehensive collection of documents and data that a manufacturer compiles to support the application for regulatory approval of a drug product and a strategy used by brand name pharmaceutical companies to extend a drug's commercial lifespan beyond its original patent's expiry.

Industry Performance of the Generic Pharmaceutical Manufacturing industry in Ontario

Benchmark the Generic Pharmaceutical Manufacturing in Ontario industry performance with all ON Census Metropolitan Area and national performance.

Generic Pharmaceutical Manufacturing in Ontario

#1 in Highest Revenue 42.4% of province's GDP
Revenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)

Generic Pharmaceutical Manufacturing in Canada


Revenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)

For the full list of industry drivers, see report purchase options.

Key Drivers of the Generic Pharmaceutical Manufacturing industry in Ontario

See how key industry drivers, such as gross domestic product, private investment in non-residential construction, bachelorsed, total health expenditure, research and development expenditure and number of adults aged 65 and older are impacting Generic Pharmaceutical Manufacturing in Ontario

Ontario Economic Indicators

Gross Domestic Product
Private Investment in Non-Residential Construction
BachelorsEd

View more economic information in ON State Economic profile

Canada Key External Drivers

Total health expenditure
Research and development expenditure
Number of adults aged 65 and older

For the full list of industry drivers, see report purchase options.

Census Metropolitan Area Data of the Generic Pharmaceutical Manufacturing industry in Ontario

Access proprietary data on Census Metropolitan Area in the Generic Pharmaceutical Manufacturing in Ontario, such as Toronto, Ottawa - Gatineau and Hamilton. Data includes figures on revenue, establishments, employees and wages by Census Metropolitan Areas.

Key Statistics of the Generic Pharmaceutical Manufacturing industry in Ontario

Download 18 years of historical data and 5 years of projected performance.

Need a deeper insight?
Get a free tour.

Free Tour

Top Questions Answered in this Report

Unlock comprehensive answers and precise data upon purchase. View purchase options.

What is the market size of the Generic Pharmaceutical Manufacturing industry in Ontario in 2025?

The market size of the Generic Pharmaceutical Manufacturing industry in Ontario is $1.3bn in 2025.

How many businesses are there in the Generic Pharmaceutical Manufacturing industry in Ontario in 2025?

There are 114 businesses in the Generic Pharmaceutical Manufacturing industry in Ontario, which has been growing at an average annual rate of 3.1% from 2020 to 2025.

Has the Generic Pharmaceutical Manufacturing industry in Ontario grown or declined over the past 5 years?

The market size of the Generic Pharmaceutical Manufacturing industry in Ontario has been declining at an average annual rate of -4.5% from 2020 to 2025.

How many employees in the Generic Pharmaceutical Manufacturing industry in Ontario in 2025?

There are 2,960 employees in the Generic Pharmaceutical Manufacturing industry in Ontario, which has been growing at an average annual rate of 3.9% from 2020 to 2025.